Educational guide
Peptides in Mental Health: A New Frontier
Ellenbogen, M. A., Cardoso, C., Serravalle, L., Vadaga, K., & Joober, R. (2024). The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial. Psychological Medicine, 54(9), 2122–2132. h
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Ellenbogen, M. A., Cardoso, C., Serravalle, L., Vadaga, K., & Joober, R. (2024). The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial. Psychological Medicine, 54(9), 2122–2132. https://doi.org/10.1017/S0033291724000217
Hendershot, C. S., Bremmer, M. P., Paladino, M. B., Kostantinis, G., Gilmore, T. A., Sullivan, N. R., Tow, A. C., Dermody, S. S., Prince, M. A., Jordan, R., McKee, S. A., Fletcher, P. J., Claus, E. D., & Klein, K. R. (2025). Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 82(4), 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789
Lähteenvuo, M., Tiihonen, J., Solismaa, A., Tanskanen, A., Mittendorfer-Rutz, E., & Taipale, H. (2025). Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. JAMA Psychiatry, 82(1), 94–98. https://doi.org/10.1001/jamapsychiatry.2024.3599
Orr, M. E., Kotkowski, E., Ramirez, P., Bair-Kelps, D., Liu, Q., Brenner, C., Schmidt, M. S., Fox, P. T., Larbi, A., Tan, C., Wong, G., Gelfond, J., Frost, B., Espinoza, S., Musi, N., & Powers, B. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. Geroscience, 46(1), 665–682. https://doi.org/10.1007/s11357-023-00999-9
Szarvas, Z., Reyff, Z. A., Peterfi, A., Pinto, C. B., Owens, C. D., Kaposzta, Z., Mukli, P., Pinaffi-Langley, A. C. D. C., Adams, C. A., Muranyi, M., Palacios, F. S., Hawkins, B., Baur, J. A., Velez, F. S., Prodan, C. I., Kirkpatrick, A. C., Csiszar, A., Ungvari, Z., Balasubramanian, P., … Yabluchanskiy, A. (2025). Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial. Journal of Pharmacology and Experimental Therapeutics, 392(7), 103607. https://doi.org/10.1016/j.jpet.2025.103607
Wang, C., Ouk, M., Chen, Y., Zhao, Y., Goodarzi, M. O., Aikens, R. C., Khoudary, S. R. E., & Chang, S. C. (2024). Associations of semaglutide with incidence and recurrence of alcohol use disorder in a real-world population. Nature Communications, 15(1), 5819. https://doi.org/10.1038/s41467-024-48780-6
Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebriakova, E. V., Siranchieva, O. A., Andriushenko, A. V., Telesheva, E. S., Siuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii Imeni S. S. Korsakova, 108(4), 38–48. https://pubmed.ncbi.nlm.nih.gov/18454096/